Oxidative Stress in Chronic Liver Disease and Portal Hypertension: Potential of DHA as Nutraceutical
Zoe Boyer‐Díaz, Jordi Gracia‐Sancho(University Hospital of Bern), Jaime Bosch(University of Bern), Albert Gibert‐Ramos(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Peio Aristu-Zabalza(Departament de Salut), Paloma Morata
Cited by 26
Related Papers
Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease
|Journal of Hepatology|2020|163
Global burden of disease attributable to metabolic risk factors in adolescents and young adults aged 15–39, 1990–2021
|Clinical Nutrition|2024|44